Identification and characterization of small-molecule inhibitors of Tie2 kinase

被引:7
|
作者
Liu, Jinqi [1 ]
Lin, Tsung H. [1 ]
Cole, Andrew G. [2 ]
Wen, Rong [3 ]
Zhao, Lian [3 ]
Brescia, Marc-Raleigh [2 ]
Jacob, Biji [1 ]
Hussain, Zahid [2 ]
Appell, Kenneth C. [1 ]
Henderson, Ian [2 ]
Webb, Maria L. [1 ]
机构
[1] Pharmacopeia Inc, Dept Biol, Cranbury, NJ 08512 USA
[2] Pharmacopeia Inc, Dept Chem, Cranbury, NJ 08512 USA
[3] Univ Penn, Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA
关键词
Tie2; small-molecule inhibitor; solubility; stability; CYP450; selectivity; angiogenesis; choroidal neovascularization;
D O I
10.1016/j.febslet.2008.02.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiopoietins and Tie2 receptor were recently identified as an endothelial cell-specific ligand-receptor system that is critical for vascular development and postnatal pathologic angiogenesis by mediating vascular integrity. In this study, we identified a series of small-molecule Tie2 inhibitors, which blocked Ang1-induced Tie2 autophosphorylation and downstream signaling with an IC50 value at 0.3 mu M. Further optimization yields improved selectivity, aqueous solubility, microsomal stability and cytochrome P450 profile for one of the compounds (compound 7). Both compound I and compound 7 inhibit endothelial cell tube formation. Furthermore, in a rat model of Matrigel-induced choroidal neovascularization, compound 7 significantly diminished aberrant vessel growth. Our findings demonstrate a potential clinical benefit by specifically targeting Tie2-mediated angiogenic disorders. (c) 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:785 / 791
页数:7
相关论文
共 50 条
  • [31] Interaction of the small-molecule kinase inhibitors tofacitinib and lapatinib with membranes
    Haralampiev, Ivan
    Alonso de Armino, Diego Javier
    Luck, Meike
    Fischer, Markus
    Abel, Tobias
    Huster, Daniel
    Di Lella, Santiago
    Scheidt, Holger A.
    Mueller, Peter
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2020, 1862 (11):
  • [32] Small-molecule EGFR tyrosine kinase inhibitors for the treatment of cancer
    Lee, Chieh-Chien
    Shiao, Hui-Yi
    Wang, Wen-Chieh
    Hsieh, Hsing-Pang
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (10) : 1333 - 1348
  • [33] Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
    Pasi A. Jänne
    Nathanael Gray
    Jeff Settleman
    Nature Reviews Drug Discovery, 2009, 8 : 709 - 723
  • [34] Fungal Infections with Ibrutinib and Other Small-Molecule Kinase Inhibitors
    Zarakas, Marissa A.
    Desai, Jigar, V
    Chamilos, Georgios
    Lionakis, Michail S.
    CURRENT FUNGAL INFECTION REPORTS, 2019, 13 (03) : 86 - 98
  • [35] Mechanism and consequences of RAF kinase activation by small-molecule inhibitors
    Holderfield, M.
    Nagel, T. E.
    Stuart, D. D.
    BRITISH JOURNAL OF CANCER, 2014, 111 (04) : 640 - 645
  • [36] Biochemical Mechanisms of Resistance to Small-Molecule Protein Kinase Inhibitors
    Krishnamurty, Ratika
    Maly, Dustin J.
    ACS CHEMICAL BIOLOGY, 2010, 5 (01) : 121 - 138
  • [37] Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
    Jaenne, Pasi A.
    Gray, Nathanael
    Settleman, Jeff
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (09) : 709 - 723
  • [38] Intraindividual Pharmacokinetic Variability: Focus on Small-Molecule Kinase Inhibitors
    Chatelut, Etienne
    Bruno, Rene
    Ratain, Mark J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (06) : 956 - 958
  • [39] Fungal Infections with Ibrutinib and Other Small-Molecule Kinase Inhibitors
    Marissa A. Zarakas
    Jigar V. Desai
    Georgios Chamilos
    Michail S. Lionakis
    Current Fungal Infection Reports, 2019, 13 : 86 - 98
  • [40] Impact of Selected Small-Molecule Kinase Inhibitors on Lipid Membranes
    Luck, Meike
    Fischer, Markus
    Werle, Maximilian
    Scheidt, Holger A.
    Mueller, Peter
    PHARMACEUTICALS, 2021, 14 (08)